Back to Market Feed

Product Information

CIMZIA 2X200 MG/ML SYRINGE KIT is a brand product labeled by UCB, Inc., priced at $6094.0250 per EA under NDC 50474071079. Its NADAC has been published 665 times since Nov 28, 2013.

CIMZIA 2X200 MG/ML SYRINGE KIT

certolizumab pegol
$6094.0250per EA

Strength

200 mg/mL

Manufacturer

UCB, Inc.

NDC

50474071079

Classification

Brand

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Effective Date

8/19/2026

Active Ingredients

CERTOLIZUMAB PEGOL

Approval Type

Biologic (BLA)

FDA Application

BLA125160

On Market Since

5/14/2009

Pharmacological Classes

Tumor Necrosis Factor Blocker
Tumor Necrosis Factor Receptor Blocking Activity

Price Statistics

The NADAC for CIMZIA 2X200 MG/ML SYRINGE KIT has been published 665 times since Nov 28, 2013, and over the history we have for it it has risen 147.8%. The table below summarizes its recorded NADAC range and movement.

Current price$6094.0250 per EA
All-time high$6120.2638 (Jul 15, 2026)
All-time low$2442.0936 (Dec 18, 2013)
52-week high$6120.2638
52-week low$5816.3608
Median price$4474.0753
Average price$4355.7764
Largest weekly change+9.9% (Jan 14, 2015)
Weeks tracked665
Tracking sinceNov 28, 2013

Price History

1W

+0.0%

1M

+0.0%

3M

-0.4%

6M

-0.3%

1Y

+4.8%

3Y

+16.4%

5Y

+29.8%

All

+147.8%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 0% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

Save up to 0%

1 alternative • Same active ingredient

CIMZIA 2X200 MG/ML(X3)START KT
Brand
50474071081•UCB, Inc.
$6072.5137
Save 0%

Related Drugs

Same classification

REMICADE 100 MG VIAL
Brand
57894003001•Janssen Biotech, Inc.
$1135.9660
per EA
ENBREL 50 MG/ML SYRINGE
Brand
58406002104•Immunex Corporation
$2080.6750
per ML
ENBREL 50 MG/ML MINI CARTRIDGE
Brand
58406004404•Immunex Corporation
$2080.9950
per ML
ENBREL 50 MG/ML SURECLICK
Brand
58406003204•Immunex Corporation
$2083.6232
per ML
ENBREL 25 MG/0.5 ML SYRINGE
Brand
58406001004•Immunex Corporation
$2086.2042
per ML
SIMPONI 100 MG/ML PEN INJECTOR
Brand
57894007102•Janssen Biotech, Inc.
$7446.2126
per ML
SIMPONI 50 MG/0.5 ML PEN INJEC
Brand
57894007002•Janssen Biotech, Inc.
$12909.9420
per ML
SIMPONI 50 MG/0.5 ML SYRINGE
Brand
57894007001•Janssen Biotech, Inc.
$12977.2440
per ML

Frequently asked questions

What is the NADAC price of CIMZIA 2X200 MG/ML SYRINGE KIT?

The current National Average Drug Acquisition Cost (NADAC) for CIMZIA 2X200 MG/ML SYRINGE KIT, manufactured by UCB, Inc., is $6094.0250 per EA (NDC 50474071079), effective Aug 19, 2026.

How has the price of CIMZIA 2X200 MG/ML SYRINGE KIT changed over time?

Over the history we have for it, the NADAC for CIMZIA 2X200 MG/ML SYRINGE KIT has risen 147.8%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for CIMZIA 2X200 MG/ML SYRINGE KIT?

Since Nov 28, 2013, the NADAC for CIMZIA 2X200 MG/ML SYRINGE KIT has ranged from a low of $2442.0936 (Dec 18, 2013) to a high of $6120.2638 (Jul 15, 2026), with a median of $4474.0753 per EA.

Are there cheaper alternatives to CIMZIA 2X200 MG/ML SYRINGE KIT?

Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CIMZIA 2X200 MG/ML(X3)START KT, is $6072.5137 per EA — about 0% below CIMZIA 2X200 MG/ML SYRINGE KIT.

Who manufactures CIMZIA 2X200 MG/ML SYRINGE KIT?

CIMZIA 2X200 MG/ML SYRINGE KIT (NDC 50474071079) is labeled by UCB, Inc., and CMS classifies it as a brand product.